Shiven Ruparel

Shiven Ruparel

Sr. Director, Product Management, Delivery and Devices

April 17, 2025

Optimizing Drug Delivery: The Strategic Advantages of User-Loaded Drug Delivery Devices

The landscape of drug delivery systems is rapidly evolving, with wearable devices and autoinjectors at the forefront, offering patients greater convenience and autonomy in managing chronic conditions. A key design consideration with such devices is whether the drug container comes preloaded with the device or is user-loaded. This article explores the strategic advantages of user-loaded designs, emphasizing the benefits of separating the drug from the device, enhancing patient safety and usability, and minimizing the costly waste of expensive medications.

Patient securely attaching medication cartridge to the drug delivery device for precise dosing

Key Benefits of User Loaded Devices

Preservation Of Drug Integrity and Minimizing Waste

One of the primary advantages of a user-loaded device design is that it allows users to preserve the drug in the event of device failure. While autoinjectors are generally reliable1, device-related issues, such as a mechanical jam or defective component can add up to 25% of the total failures2. With a user-loaded system, the separate drug container or cartridge can be salvaged and used with a functional device, preventing waste and ensuring timely access to medication. needed. Given the increasing cost of medications, minimizing waste is not only ethically responsible but also financially prudent. User-loaded designs allow for preventing drug waste due to device malfunctions.

Visual Inspection of Drug Quality

Separating the drug from the delivery device enables patients to visually inspect the drug for abnormalities such as discoloration or particulates prior to administration. This inspection is crucial for ensuring drug safety, allowing patients to identify potential issues that arise during transportation or storage. The European Medicines Agency (EMA) emphasizes that the color of a drug substance is a key characteristic, and any changes during storage should be investigated. Preloaded systems may obscure the drug from view, increasing the risk of administering compromised medication.

Enhanced Storage Efficiency

User-loaded device designs can significantly enhance storage efficiency, particularly for drugs requiring refrigeration. By allowing patients to store only the drug cartridge at cold temperatures, rather than the entire device in the patient packaging, space can be saved in both home storage and possibly during transport as well. This separation is especially beneficial for patients managing multiple medications or those who need to travel with their medication.

Ease of Use and Patient Confidence 

Despite the additional loading step, well-designed user-loaded devices maintain high levels of usability and patient confidence. For instance, in a study evaluating an on-body injector (OBI), which uses a prefilled cartridge that patients must load, 97% of patients reported that it was “easy” or “very easy” to use, and 93% felt “very” or "extremely confident” in self-injecting at home after proper training3,4. These statistics demonstrate that patients can adapt to user-loaded systems with minimal burden when supported by effective design and training.

Addressing Concerns and Looking Ahead Steps

While some may argue that requiring patients to load cartridges adds complexity, the benefits of preserving drug integrity, enabling visual inspections, optimizing storage, and minimizing the financial impact of wasted high-value medications significantly outweigh this concern. User-centered design and comprehensive training can further mitigate any potential challenges, ensuring a seamless and safe user experience.

The growing adoption of wearable drug delivery systems for chronic conditions, particularly for large-volume subcutaneous biologics, positions user-loaded designs, like the SmartDose systems , as a compelling strategic opportunity. By prioritizing usability and incorporating patient insights, pharmaceutical companies can leverage these devices to create differentiated solutions that optimize patient outcomes and enhance financial performance.

References:

1. Dostal P, Taubel J, Lorch U, Aggarwal V, York T. The Reliability of Auto-Injectors in Clinical Use: A Systematic Review. Cureus. 2023 Jul 9;15(7):e41601. doi: 10.7759/cureus.41601. PMID: 37559861; PMCID: PMC10409493.
2. Machal ML. Risks and benefits associated with the primary functions of artificial intelligence powered autoinjectors. Front Med Technol. 2024 Apr 5;6:1331058. doi: 10.3389/fmedt.2024.1331058. PMID: 38645777; PMCID: PMC11026574.
3. On-Body Injector - SKYRIZI® (risankizumab-rzaa) for Ulcerative Colitis. (n.d.). https://www.skyrizihcp.com/gastroenterology/ulcerative-colitis/dosing/skyrizi-on-body-injector